Replies to post #119187 on Biotech Values

[biotech jim]

When I clicked on the Peptimmune Citizen's petition, the link does not work. Is this link no longer effective, or is it me or my 'puter?

Also, someone stated over the last couple of days that there are several "markers of activity" for copaxone, but to my knowledge none of these "assays" have been validated as to being essential for activity in MS patients or in animal models for that matter IMHO.

BJ

[iwfal]

Copaxone PK/PD can be measured

There is a difference between PK/PD, especially aggregate PK/PD, and measuring a biomarker of activity (which was what investorsgold asked about when he compared to anti-IIA activity for Lovenox).

Obviously this might be excusable since plenty of aspects of Lovenox are not fully understood/characterized and yet m-enox was approved. But I think it undebatable that less end-effect characterization will have to suffice for Copaxone.